Dr. Prabhu Nesargikar is a highly experienced surgical oncologist, and his expertise lies in Gastrointestinal robotic surgery, surgical gastroenterology, and advanced endoscopic surgery. He specialises in the management of all major GI malignancies, namely esophageal cancers, stomach cancer, small intestine cancer, and colorectal cancer, along with peritoneal malignancies. He takes a holistic approach to treatment and is committed to providing the best possible care for his patients.
Dr. Prabhu Nesargikar is a Consultant in GI (Gastrointestinal) and Peritoneal Cancer Surgery, and Surgical Gastroenterology
Dr Prabhu is the clinical lead for GI Robotic and Minimally Invasive surgeries
International pedigree of more than 20 years having trained exclusively in the United Kingdom, Singapore, and S. Korea, and was a former Assoc Consultant in Surgery at National University Hospital, Singapore.
Dr. Prabhu is one of the select few surgeons who offer a comprehensive approach to gastro-intestinal cancers (Esophagus, Stomach, Intestine, Colon, Rectum) from organ-preserving endoscopic surgery to minimally invasive surgeries (laparoscopic and robotic)
He is experienced in Peritoneal Cancer treatment including multiorgan cytoreductive surgery and PIPAC, IP Chemotherapy, and HIPEC Surgeries
He leads the Preventive Oncology programme including screening healthcare intitiatives
He is JAG (UK) certified endoscopist and proficient in daycare endoscopy procedures like Colonoscopy, Upper GI endoscopy, EMR/ ESD for small tumors, PEG Tube insertions, and endoscopic stenting procedures
Tan Lly, Xuan G, Nesargikar PN et al. Low Molecular weight heparin use and thrombotic complications in upper gastrointestinal resection for malignancy in a multi- ethnic Asian population. Asian J of Surg.2024 Jan
Sewanti L, Nesargikar PN et al. Response to Pazopanib-based Combination Regimen in a Case of FGFR3 Amplified Gastric Adenocarcinoma. Clinical Case Reports 2021
STARSurg Collaborative. Critical care usage after major gastrointestinal and liver surgery: a
prospective, multicentre observational study. Br J Anaesth. 2019 Jan.
EUROSURG Collaborative. Body mass index and complications following major gastrointestinal
surgery: a prospective, international cohort study and meta-analysis. Colorectal Dis. 2018 Aug
STARSurg Collaborative. Safety of Nonsteroidal Anti-inflammatory Drugs in Major Gastrointestinal
Surgery: A Prospective, Multicenter Cohort Study. World J Surg 2017
Khalid U, Gilda Pino-Chavez, Nesargikar PN et al. Kidney ischaemia reperfusion injury in the rat: the EGTI scoring system as a valid and reliable tool for histological assessment. Journal of Histology & Histopathology 2016.
STARSurg Collaborative. Multicentre prospective cohort study of body mass index and
postoperative complications following gastrointestinal surgery. Br J Surg 2016
Nesargikar PN, Spiller B, Chavez RC. The Complement System: History, Pathways, Cascade and
inhibitors. Eur J of Micr Immuno 2012
Nesargikar PN, Kaur V, Cocker DM, Lengyel J. Consenting for pelvic nerve injury in colorectal
surgery: Need to address age and gender bias. Ann R Coll Surg Engl 2010
Nesargikar PN. From student to tutor in Problem Based Learning: An unexplored avenue. BJMP
2010; 3:313
Harji DP, Nesargikar PN et al. Immunoprophylaxis in Asplenic Patients. Int J Surg 2009
Nesargikar PN, Granell M, Houghton A. Newton’s Law to the rescue: Therapeutic effects of gravity aiding the management of a migratory venous foreign body– A Case Report. Vasc Endovascular Surg 2009
Nesargikar PN, Jaunoo S. Natural Orifice Translumenal Endoscopic Surgery – A review. Int J Surg
2009 Jun
Nesargikar PN, Ajith MK, Eyers PS, Nichols B, Chester JF. Lumbar Chemical Sympathectomy in
Peripheral Vascular Disease- Does it still have a role? Int J Surg 2009.
Dr. Prabhu is the recipient of several awards of accolades including the prestigious “Young Investigator Award” at ESOT Congress, Belgium for his research in renal ischemia reperfusion injuries
Awards at the Japanese and Korean Gastric Cancer Congress
He topped the National interviews in the United Kingdom to enter the higher specialist training in NHS
He is a member of multiple reputed international and national associations like IASO, IAGES, OSSI, IFSO, AUGIS, and ASI.
Dr. Prabhu has authored a good number of publications International journals, and chapters in the medical school curriculum
Recipient of ESMO GI Preceptorship Programme, Singapore, 2018.
Dr. Prabhu is a UK-Board Certified Surgeon with CCT ( Certificate of Completion of Training) from the General Medical Council
He has attended Gastric Cancer Masterclass Fellowship Programme at SNUH, S.Korea
Dr. Prabhu has obtained Fellowship- FRCS from RCS, Edinburgh, and MRCS from RCS, England
He was awarded MD for his research from Cardiff University, UK He was awarded an MA degree in Medical Education from Keele University, UK
He has completed Leadership and Management programme from NHS, Scotland, and is a strong advocate of ‘Patient safety and Human Factors’ in Surgery’
He is a Surgical Tutor in the ChM Surgical Teaching Programme, University of Edinburgh.
MBBS, MD (Paediatrics), DM (Medical Oncology), ESMO (European Society of Medical Oncology), FRCP (Edin)
HCG Cancer Center - DR BLR,HCG Cancer Center - KR BLR
View Profile Book an Appointment
Mbbs MD. DNB ( Radiation oncology)
HCG Cancer Center - DR BLR,HCG Cancer Center - KR BLR
View Profile Book an Appointment
MBBS, MS (Orthopaedics)
HCG Cancer Center - DR BLR,HCG Cancer Center - KR BLR
View Profile Book an AppointmentMBBS, MD (General Medicine), DM (Medical Oncology)
HCG Cancer Center - DR BLR,HCG Cancer Center - KR BLR
View Profile Book an Appointment
MBBS, MD (General Medicine), DM (Medical Oncology), MRCP UK, MRCP SCE in Medical Oncology, ESMO Certification
HCG Cancer Center - DR BLR,HCG Cancer Center - KR BLR
View Profile Book an Appointment
MBBS (General Surgery), MCh (Surgical Oncology), FMAS
HCG Cancer Center - DR BLR,HCG Cancer Center - KR BLR
View Profile Book an Appointment
